目的检测脊髓性肌萎缩症(SMA)患者神经元样细胞SMN2基因mRNA的表达。方法用PCR-RFLP的方法对SMA患者进行基因诊断,诱导其骨髓间充质干细胞分化为神经元样细胞,RT-PCR和测序检测该细胞SMN2基因mRNA的表达,所有过程与对照组进行对比研究。结果SMN2基因的扩增产物为全长转录产物fl-SMNmRNA(266bp)和转录时跳过外显子7的产物SMN△7mRNA(212bp,经测序证实缺少的54bp为外显子7的序列);SMA患者fl-SMNmRNA的表达占总表达量的23.2%,远低于对照者(占总表达量的82.0%);而SMN△7mRNA表达占总表达量的76.8%,高于对照者的18.0%。结论SMA患者神经元样细胞的SMN2基因转录时存在选择性剪接,即剪接时跳过外显子7,是导致其全长SMN蛋白不足的原因之一。
Objective To detect the difference of SMN2 mRNA expression between the neuron-like cells(NLCs) derived from patients with spinal muscular atrophy (SMA). Methods Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was performed to diagnose the patients with SMA and the controls. Mesenchymal stem cells (MSCs) were induced into neuron-like cells which become the models of neurons. The transcripts of SMN2 were testified with RT-PCR combined with sequencing. Results Two bands(266 bp and 212 bp) were found in the gel picture of RT-PCR and the band of 266 bp was the full length transcript( fl-SMN mRNA). The band of 212 bp was testified by sequencing to be deletion of the exon 7, which was the production of alternative splicing ( skipping exon 7, SMNA7 mRNA). The expression of fl-SMN mRNA accounted for 23.2% of the total SMN mRNA in the SMA patients, being much lower than the rate in the controls (82.0%). In contrast, 76. 8% of SMN gene transcripts was SMNA7 mRNA in the SMA patients, being much higher than the rate of 18% in the controls. Conclusions Alternative splicing exists in SMN2 gene transcription, that is, exon 7 is skipped during the processing of SMN2 mRNA in the NLCs of SMA patients, which is one of the reasons of the full-length SMN protein lacking.